Diffusion Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch DFFN and buy or sell other stocks, ETFs, and their options commission-free!

About DFFN

Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. 

CEO
Robert J. Cobuzzi
CEORobert J. Cobuzzi
Employees
16
Employees16
Headquarters
Charlottesville, Virginia
HeadquartersCharlottesville, Virginia
Founded
2001
Founded2001
Employees
16
Employees16

DFFN Key Statistics

Market cap
758.61M
Market cap758.61M
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
2.12M
Average volume2.12M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$0.8551
52 Week high$0.8551
52 Week low
$0.166
52 Week low$0.166
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.